Advanced Lung Cancer
The Effect of a Psycho Educational Intervention on Quality of Life of Patients with Advanced Lung Cancer Undergoing Chemotherapy
5
Process of Decision Making of Anti Cancer Treatment in Elderly Patients with Advanced Lung Cancer
16
Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta analysis
9
<p>Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy</p>
9
Multiple Chemotherapy-Based Combination Therapy Strategies for Advanced Lung Cancer Patients: A Systematic Review and Network Meta-Analysis
31
Diagnostic and Prognostic Value of Serum Tissue Polypeptide Antigen in Advanced Lung Cancer
7
Subclavian thrombosis in a patient with advanced lung cancer: a case report
5
Qualitative critical incident study of patients’ experiences leading to emergency hospital admission with advanced respiratory illness
10
Afatinib treatment in advanced non-small cell lung cancer
11
Gefitinib for advanced non small cell lung cancer
270
Effective nivolumab sequential thoracic radiotherapy in elderly patients with advanced squamous cell lung cancer: did radiation therapy play a role? A case report
9
First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
6
New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib
14
Emerging strategies for the treatment of advanced small cell lung cancer.
12
Pattern of Primary Lung Cancers
102
Developments in the Management of Advanced Non Small Cell Lung Cancer
6
Primary tumors induce neutrophil extracellular traps with targetable metastasis-promoting effects
14
Respiratory Cancerous Cells Detection Using TRISS Model and Association Rule Mining
6
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring <em>EGFR </em>mutations: subgroup analysis of the LUX-Lung 6 trial
13
Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival
14